One-shot Sputnik Light vaccine shows 70% efficacy against Delta variant of COVID-19: RDIF


Content Team
Image Credit: Shortpedia

The Russian Direct Investment Fund (RDIF) and Gamaleya Center on Wednesday said one-shot Sputnik Light vaccine demonstrates 70% efficacy against infection with the Delta variant of coronavirus during the first three months after vaccination. Gamaleya Center has submitted an article analysing the efficacy of the Sputnik Light vaccine against the Delta variant to the medRxiv preprint server for health sciences, RDIF said.